Scientific publications

Monocytic dysfunction by opioid peptides in patients with major depression

Castilla A, Subirà ML, Civeira MP [SP], Cuende JI, Prieto J.
Departamento de Medicina Interna, Universidad de Navarra, Pamplona

Magazine: Medicina Clínica

Date: Sep 1, 1992

Hepatology

BACKGROUND
Patients with depression present immunodepression and it has been proposed that, in these patients, endogenous opioid peptides may be mediators between the dysfunction of the central nervous system and immune alterations.

METHODS
The function and the surface markers of monocytes were studied in 15 patients with major unipolar depression and in 24 healthy controls by biological trials of phagocytosis of Candida albicans and latex particles and immunofluorescence with monoclonal antibodies.

RESULTS
Most of the patients studied (86%) presented monocytic dysfunction characterized by diminished phagocytic activity and a decrease in the expression of intermediate filaments of vimentin of the cytoskeleton and membrane molecules (CR1, receptor for the Fc fraction of the IgG and HLA DR antigens). Incubation of the patients monocytes with naloxone led to the disappearance of monocytic alterations in most of the patients.

CONCLUSIONS
Patients with major unipolar depression present a high opioid tone which has consequences in the function of the immune system.

CITATION  Med Clin (Barc). 1992 Sep 12;99(7):241-3

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra